PEOPLE - Inion makes appointment:
This article was originally published in Clinica
Seppo Nevalainen has been named as general manager of Inion (Tampere, Finland). Mr Nevalainen has 19 years of medtech industry experience and joins the firm from GE Healthcare where he was general manager for the life support division (Europe, Middle East and Africa). Inion specialises in the development of novel biodegradable medical implants.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.